BridGene Biosciences
Pre-clinicalBridGene Biosciences is a biotechnology company pioneering next-generation chemoproteomics (IMTAC™ platform) to discover small molecule drugs for undruggable targets in oncology, neurology, and immunology.
Founded
2018
Focus
Small Molecules
About
BridGene Biosciences is a biotechnology company pioneering next-generation chemoproteomics (IMTAC™ platform) to discover small molecule drugs for undruggable targets in oncology, neurology, and immunology.
Funding History
2Total raised: $15M
Series A$12MKaiwu CapitalJan 15, 2021
Seed$3MMorningside VenturesApr 15, 2019
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile